Intrinsic Medicine, which develops treatments for gut-related conditions using synthetic biology-manufactured human identical milk oligosaccharide (HiMO) molecules, has cancelled plans to go public in the US. Learn more about the withdrawn IPO, and find out about similar companies in which you can invest.
On July 25, 2022, Intrinsic Medicine announced it was cancelling its plans to go public. Originally, it had planned to conduct an IPO on the Nasdaq under the ticker symbol “INRX.” Altogether, the company had planned to raise around $25 million by offering 4.2 million stocks at a price of $5.00 – $7.00.
Spartan Capital Securities, LLC was slated to act as the lead underwriter of the deal. You can read more about the IPO in this prospectus submitted to the US Securities and Exchange Commission (SEC) on May 4, 2022.
Current market conditions have been cited as the reason for for the cancellation. A future IPO date has not been announced.
Even though you won’t be able to buy Intrinsic Medicine stock, you can still invest in other biotechnology companies that develop treatments for gut-related conditions.
| Company | Stock info |
|---|---|
NasdaqGS: FNCH | |
NasdaqGS: MCRB | |
NasdaqGS: EVLO | |
PureTech Health | NasdaqGM: PRTC |
You’ll need a brokerage account to buy and sell stocks. Here’s how it works:
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
These are the stocks to buy when you don’t have much to spend.
Read more…
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
Read more…
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
Read more…
Track the progress of the S&P 500 stocks to make more informed investment decisions.
See our picks for the best brokers for trading S&P 500 stocks, ETFs, options and futures.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
Stock lending allows investors to loan out their existing stocks, although it has both advantages and disadvantages.
Compare pros, cons, research tools and reviews for these two trading platforms.
Some of the best trading apps like Robinhood are SoFi, Tastytrade, Public, eToro, Acorns, Interactive Brokers, E*TRADE and more.
Compare pros, cons, research tools and reviews for these two trading platforms.
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.